New Delhi [India], June 21 (ANI): In a significant development, India’s top drug regulator has given nod to two domestic pharmaceutical companies–Cipla and Hetero for marketing authorization of anti-viral drug Remdesivir only for “restricted emergency use” o? Read More
reported by at ANI News
Recent Comments